04826oas 2201105 a 450 991033311280332120241231213015.02212-1102(DE-599)ZDB2677520-7(OCoLC)802230270(CONSER) 2012250782(CKB)3460000000023844(EXLCZ)99346000000002384420120726a20129999 uy engur|||||||||||txtrdacontentcrdamediacrrdacarrierValue in health regional issuesNew York, N.Y. Elsevier Inc.©2012-1 online resourceRefereed/Peer-reviewed2212-1099 Value in Health Regional Issues (ViHRI) is a new scientific journal of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) to encourage and enhance the science of pharmacoeconomic/health economic and health outcomes research and its use in health care decisions in Asia, Latin America, Central & Eastern Europe, Western Asia, and Africa. Value in Health Regional Issues, a peer-reviewed publication, is an independent journal (unique ISSN), and is related to Value in Health only in cover design and contents. The scope and mission of Value in Health Regional Issues is consistent with the mission and scope of the Society. Value in Health Regional Issues includes articles on health care policy analysis, outcomes research (clinical, economic, and patient-reported) empirical studies, methodological studies, and articles on health care resources in the region. Health care decision-maker commentaries that stimulate communication between health outcomes researchers and policymakers are welcome. Commentaries are expected to include discussion on how researchers can better respond to the needs of those making clinical and financial decisions in health care.ViHRIMedical technologyEvaluationPeriodicalsRegional planningEvaluationPeriodicalsMedical careEvaluationPeriodicalsPharmaceutical technologyEvaluationPeriodicalsBiotechnologyEvaluationPeriodicalsOutcome Assessment, Health CareEconomics, PharmaceuticalTechnology, MedicalstandardsHealth ResourcesstandardsRisk AssessmentMedical careEvaluationfast(OCoLC)fst01013794Medical technologyEvaluationfast(OCoLC)fst01014750Regional planningEvaluationfast(OCoLC)fst01093145Évaluation du risqueÉvaluation des résultats (Soins médicaux)PharmacoéconomieAménagement du territoireÉvaluationPériodiquesTechnologie médicaleÉvaluationPériodiquesSoins médicauxÉvaluationPériodiquesTechniques pharmaceutiquesÉvaluationPériodiquesBiotechnologieÉvaluationPériodiquesrisk assessmentaatPeriodicalPeriodicals.fastPeriodicals.lcgftMedical technologyEvaluationRegional planningEvaluationMedical careEvaluationPharmaceutical technologyEvaluationBiotechnologyEvaluationOutcome Assessment, Health Care.Economics, PharmaceuticalTechnology, MedicalstandardsHealth ResourcesstandardsRisk AssessmentMedical careEvaluation.Medical technologyEvaluation.Regional planningEvaluation.Évaluation du risque.Évaluation des résultats (Soins médicaux)Pharmacoéconomie.Aménagement du territoireÉvaluationTechnologie médicaleÉvaluationSoins médicauxÉvaluationTechniques pharmaceutiquesÉvaluationBiotechnologieÉvaluationrisk assessment.International Society for Pharmacoeconomics and Outcomes Research.AU@AU@OCLCOTXABUFTEFCUSOCLCQFIEOCLCQUABOCLCQOCLCFOCLCQOCLCOOCLCAOCLCLJOURNAL9910333112803321Value in health regional issues1892726UNINA